Continuation of supportive therapy with bisphosphonates or denosumab can also be allowed, whatever the fundamental malignancy; Moreover, that 24 months of therapy with genistein enhanced bone mineral density in osteopenic postmenopausal women [a hundred and seventy,171], suggesting that genistein can be a possible therapeutic agent for osteoporosis. Moreover, Lee et https://andersonj555fxq6.wikilima.com/user